Susan Hasty, Publisher
Table of Contents . . . July 4th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Myasthenia Gravis - Peptide Vaccine Ready For Testing In Humans
Vaccine Safety - IL-1 Production Likely Responsible For Pertussis Vaccine Side Effects
Amebiasis - Proof Of Naturally Acquired Immunity Offers Hope For Vaccine
Hepatitis Vaccines - Formulation With Three Antigens Exceeds Par In Adult Trials
Influenza - Children With Cancer Benefit From Flu Vaccine
Malaria - African Children Hold Clue To Immunity
Bioterrorism - Working Group On Civilian Biodefense Warns Tularemia Could Be Threat
Cancer Vaccines - Increased Patient Survival Follows Treatment For Metastatic Disease
Cancer Vaccines - Results Indicate Survival Benefit For Failed Chemo Patients
Colorectal Cancer - 105AD7 Vaccination Ineffective For Advanced Disease
Delivery Systems - Intra-Spleen DNA Vaccine Stimulates Lymphoid Immune Response
Delivery Systems - Mucosally Immunized Mice Exhibit Immune Memory In Old Age
HIV Vaccines - Manufacturing Agreement Reached For Plasmid DNA-Based Vaccine
Hepatitis Vaccines - FDA Approves First OSHA-Compliant, All-In-One Delivery System
Influenza A - DNA Vaccine Protects Mice Against Highly Mutational Influenza
Melanoma - Phase II Findings Of Therapeutic Vaccine Presented
Otitis Media - Cord Blood Antibodies Predict Ear Infection In Infants
Polio - Vaccine Coverage Summarized
Porphyromonas gingivalis - Immunization With Alum Allows Manipulation Of T-cell Response
Prostate Cancer - Therapeutic Vaccine For Earlier Stage Disease
Prostate Cancer - Vaccine Generates Potent Immune Response
Pseudomonas aeruginosa - Mouse Survival Prolonged With Dendritic Cell Vaccine
Shigella flexneri - Mucosal Vaccine Generates Immune Response On Par With Live Formulation
Stomach Cancer - Gastrin And Its Receptor Genes Activated At Earliest Stages
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.